Compass Therapeutics, Inc.

Historical 13F Holders

Symbol
CMPX
CUSIP
20454B104
All holders as of
Q3 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 20454B104 since 12/18/2024, largest first.

Filer % of Class Filed
Tang Capital Management LLC 13G/A
10.0% 11/14/2025
Event 9/30/2025
Orbimed Advisors LLC 13D/A
8.9% 8/15/2025
Event 8/13/2025
Suvretta Capital Management, LLC 13G/A
8.2% 8/21/2025
Event 8/13/2025
BlackRock, Inc. 13G 5.2% 1/21/2026
Event 12/31/2025
Under 5%, checked the "5 percent or less" box, or amended by a later filing (7)
Commander Aggregator, LP 13D/A
4.5% 8/18/2025
Event 8/14/2025
Adage Capital Partners GP, L.L.C. 13G/A
4.4% 2/12/2025
Event 12/31/2024
Biotechnology Value Fund L P 13G/A
4.3% 5/15/2026
Event 3/31/2026
State Street Corp 13G 4.3% 11/10/2026
Event 9/30/2026
MPM BioImpact LLC 13G/A 4.1% 8/12/2025
Event 6/30/2025
Vivo Opportunity Fund Holdings, L.P. 13G/A
4.0% 8/14/2026
Event 6/30/2026
Blackstone Holdings II L.P. 13G/A
3.4% 2/13/2026
Event 12/31/2025

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q3 176 161 M $167M
2026 Q2 216 166 M $363M
2026 Q1 204 173 M $919M
2025 Q4 172 164 M $881M
2025 Q3 125 151 M $529M
2025 Q2 105 108 M $281M
2025 Q1 120 108 M $206M
2024 Q4 93 101 M $147M
2024 Q3 80 92.2 M $170M
2024 Q2 83 92.9 M $93.4M
2024 Q1 79 94.6 M $187M
2023 Q4 78 86.1 M $134M
2023 Q3 77 89.7 M $177M
2023 Q2 74 90.5 M $288M
2023 Q1 74 81.5 M $267M
2022 Q4 56 79.8 M $401M
2022 Q3 39 63.9 M $146M
2022 Q2 35 61.9 M $164M
2022 Q1 35 62.4 M $85.4M
2021 Q4 38 63.6 M $202M